Valhalla Business Advisors is committed to empowering organizations with comprehensive and cutting-edge solutions to address the unique healthcare needs of their employees. We are thrilled to share how our strategic partnerships with leading clinical solutions providers, Tula Health and AposHealth, are revolutionizing the management of diabetes and enhancing the lives of patients struggling with MSK maladies including progressive knee OA. By embracing these clinical solutions, employers can ensure their workforce’s well-being, productivity, and overall quality of life and bring a measurable Return on Investment (ROI) for the expenditure.
Transforming Diabetes Management
According to the CDC, “[c]urrent estimates show that 1 in 3 Americans will develop diabetes sometime in their lifetime.1 Diabetes is a chronic (long-lasting) health condition that affects how the body turns food into energy and results in too much sugar in the bloodstream. Over time, this can cause serious health problems and damage vital organs. Most people who have diabetes have a shorter life expectancy than people without the disease.”
While 37 million Americans have diabetes, 96 million are estimated to have prediabetes. Aside from the health risks associated with the disease, including increased risks of heart attack, stroke, and kidney failure, there are also cost implications; According to the CDC, $1 our of every $4 in US health care costs is spent on caring for people with diabetes and “48%-64% of lifetime medical costs for a person with diabetes are for complications… such as heart disease and stroke.”
Valhalla is pleased to partner with Tula Health, who provides evidence-based, technology-driven, and intensive patient-focused initiatives which are proven to result in reductions to eye disease (76%), amputation (34%), neuropathy (60%) and nonfatal heart attack, stroke, or death from cardiovascular causes (57%).
Furthermore, this solution includes financing strategies that provide multiple pathways for clients to manage the risk (i.e. cash cost) of the Tula solutions with “at risk” contract terms.
Reach out to Valhalla to inquire about developing a group-specific proposal based upon your own organization’s profile and data!
Innovation in msk | avoiding tkr claims
A recent journal article from Michael Suk and Matthew Bartels indicates the following:
Osteoarthritis (OA) is the second most frequent chronic musculoskeletal (MSK) condition after low back pain and a leading cause of disability in the elderly. The number of people living with disability will continue to rise with the aging of the population. Moreover, the rapid increase in rates of surgical intervention, i.e. Total knee replacement (TKR) and revision TKRs, is expected to place an immense burden on the health care system and society. There is a call for better rehabilitation, new interventions, and disease management for patients with knee OA. The purpose of this article is to review the biomechanics of knee OA and biomechanical interventions and to summarize the current literature on a non-invasive, home-based biomechanical treatment for patients with knee OA. The evidence suggests an improvement in symptoms and biomechanical indicators after using the home-based biomechanical intervention. In the presence of value-based payment to improve efficiency and effectiveness in delivering medical care, these results are promising.
AposHealth, a global provider of MSK health solutions, provides an FDA cleared device in the United States, which is covered by many payers. Apos’ novel approach originated in Israel and includes a recommendation from NICE in the UK. NICE describes the Apos innovation:
AposHealth is intended to improve biomechanics by redistributing pressure away from affected areas and reducing knee pain. On a neuromuscular level, it is designed to re-educate muscles and correct abnormal gait patterns, which can extend to when the person is not actively wearing the device.
https://www.nice.org.uk/guidance/mtg76/chapter/2-The-technology
AposHealth has been subjected to extensive peer-reviewed research, including on the empirical questions of impact to avoided and delayed TKR procedures and other utilization.
Employers can realize significant cost savings associated with surgery costs and utilization avoided by engaging with the Apos solution while also enhancing employees’ quality of life.
Reach out to Valhalla to inquire about developing a group-specific proposal based upon your own organization’s profile and data!
The Valhalla advantage
As an advocate for employee well-being and productivity, Valhalla Business Advisors proudly partners with providers like Tula Health and Apos Health to provide transformative clinical solutions to large groups with diabetics and progressive knee OA. By embracing these cutting-edge approaches to healthcare, employers can offer their employees the highest level of care, leading to improved health outcomes, increased engagement, and reduced healthcare costs. To learn more about how Valhalla-vetted clinical solutions can benefit your organization, reach out to our team today. Together, let’s shape a healthier and more mobile future for your workforce! It is a battle worth fighting!!